Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
10/27/2022* -- Results Q3 2022 -- 0.76 --
10/27/2022* 16:30 EST Earnings Call Q3 2022 -- -- --
07/27/2022 16:30 EST Earnings Call Q2 2022 -- -- --
07/27/2022 -- Results Q2 2022 0.76 0.75 1.80%
05/04/2022 -- Results Q1 2022 0.70 0.62 13.18%
05/04/2022 16:30 EST Earnings Call Q1 2022 -- -- --
01/26/2022 -- Results Q4 2021 1.07 1.03 4.13%
01/26/2022 16:30 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 10/27/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 07/27/2022
Beat/Miss Upgrade
Return Since -24.99%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%.
URL https://www.conmed.com
Investor Relations URL https://www.conmed.com/en-US/Investor-Relations
HQ State/Province Florida
Sector Healthcare
Industry Medical Devices
Equity Style Small Cap/Blend
Next Earnings Release Oct. 27, 2022 (est.)
Last Earnings Release Jul. 27, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Sep. 14, 2022

Dividends

Dividend Per Share (TTM) 0.80
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.7188
Yield to Sector 0.5542
Yield to Industry 0.5849
Last Dividend Amt. 0.20
Dividend Frequency Quarterly
Last Ex-Dividend Date Sep. 14, 2022
Yield (TTM) 0.99%
Forward Yield 1.03%
Payout Ratio -20.58%
Cash Payout Ratio 41.82%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-0.43%
2.19%
17.32%
27.39%
75.72%
1.14%
27.35%
-44.82%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-22.58%
-67.80%
-28.59%
-49.84%
-47.69%
-93.17%
229.0%
-48.60%
-36.96%
-87.17%
63.37%
16.67%
-79.93%
-17.17%
8.91%
-45.97%
-68.64%
-44.57%
-56.37%
48.58%
-52.96%
5.47%
10.67%
-77.09%
26.25%
-9.04%
-23.93%
70.05%
-17.52%
10.42%
-13.60%
-24.30%
-55.20%
As of September 27, 2022.

Profile

Edit
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%.
URL https://www.conmed.com
Investor Relations URL https://www.conmed.com/en-US/Investor-Relations
HQ State/Province Florida
Sector Healthcare
Industry Medical Devices
Equity Style Small Cap/Blend
Next Earnings Release Oct. 27, 2022 (est.)
Last Earnings Release Jul. 27, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Sep. 14, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
CSMVX 9.300M USD 2.49%
PSCH 7.262M USD 2.36%
CIPSX 56.50M USD 2.23%
TCGRX 6.954M USD 2.07%
HSVRX 39.35M USD 2.00%
PMDDX 18.96M USD 1.79%
PNSBX 11.02M USD 1.59%
RNMC 152682.0 USD 0.97%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter CNMD Tweets